For the first time, a malaria vaccine that uses the entire malaria parasite has proven safe and shown promise to produce a strong immune response in a clinical trial, according to a new study co-authored by researchers at the University of Maryland School of Medicine Center for Vaccine...
Better communication is needed around HIV vaccine trials to ensure those in at-risk communities understand the process and continue to participate, according to a new University of Toronto study. The study - published in the September edition of the American Journal of Public Health - centred...
Children younger than 3 years old receive the same protective antibody response from the recommended two doses of licensed seasonal influenza vaccines regardless of whether the two doses are injected by needle, inhaled through a nasal spray or provided through one dose of each in any order...
Researchers have developed a new candidate vaccine to protect against chikungunya virus, a mosquito-borne pathogen that produces an intensely painful and often chronic arthritic disease that has stricken millions of people in India, Southeast Asia and Africa. A single dose of the experimental...
Officials in Nigeria's northern Kano state say parents who refuse to have their children vaccinated against polio may be prosecuted and could face jail time. The government order issued this week comes as the United Nations children's agency, UNICEF, has been pressuring Nigeria's northern...
Almost a quarter million people are hospitalized with the flu every year, and an estimated 3,000 to 49,000 die, making the flu one of the chief causes of preventable death in the USA. However, a universal flu vaccine that protects against all strains may be within reach in the next five years...
About 200,000 people are hospitalized with the flu every year, and an estimated 3,000 to 49,000 die, making the flu one of the chief causes of preventable death in the USA. However, a universal flu vaccine that protects against all strains may be within reach in the next five years that will...
Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that novel data from a preclinical study of its SynCon™ DNA vaccine against HIV were published in two separate scientific...
I am writing to alert you to a story that has been grossly under-reported but is vitally important to infant health and the fight against meningitis. Meningitis is a rare disease, but it's a leading cause of preventable deaths in infants. The Food and Drug Administration (FDA) has already...
A potential vaccine against bacteria that cause serious gastric disorders including stomach cancer may be a step closer following a pioneering study by a University of Guelph chemist. In the first published study of its kind, a team led by Prof. Mario Monteiro, Department of Chemistry, found a...
Profectus Biosciences, Inc., a leader in the development of therapeutic and preventive vaccines against infectious diseases and cancers, announced that its GENEVAX™ IL-12 pDNA adjuvant has significantly improved the vaccine-induced response rate in a Phase I clinical study of an experimental DNA...
I am pretty sure one of my tollers is logging on to his Y!A account and reporting all my questions. I mean rational, intelligent human beings could not lack a sense of humor so, and be so dense! Is there a vaccine for this? Can it be administered to Humans? Can it be administered via Email...
GlaxoSmithKline (GSK) and JSC Binnopharm (Binnopharm) announced an alliance to enable the local secondary manufacture of a number of GSK vaccines in Russia. The agreement was signed in Moscow during the session of the Russian-British Intergovernmental Steering Committee (ISC) for Trade and...
The average price of a vaccine that protects children against five diseases is expected to "drop to $2.58 next year compared to the current average price of $2.97," the GAVI Alliance said Friday, Reuters reports. The group credits the expected price decline, which "represents a decrease of 30...
Babies under two have second the highest rates of flu, after the elderly. Giving them the flu vaccine has been found to be effective in preventing influenza. Researchers from Turku University Hospital, Finland wrote in the medical journal The Lancet Infectious Diseases that vaccination...
NPR's "Shots" blog examines progress in the search for a vaccine to protect against the dengue virus. WHO "estimates that 2.5 billion people worldwide are at risk of getting dengue, and most of them are in Asia and Latin America," the blog writes. Annually, between 250,000 and 500,000...
London Genetics Limited, an expert in the use of pharmacogenetics in clinical drug discovery and development, and Astrimmune, which is focused on gastrointestinal cancers, are pleased to announce that they have entered into a collaboration to plan a biomarker identification programme. The plan...
Pevion Biotech AG today announced positive preliminary results from a Phase I study of PEV7, the first vaccine against recurrent vulvovaginal candidiasis (RVVC). Also known as chronic recurrent thrush, RVVC is a highly debilitating condition, which affects an estimated 3-6% of women worldwide...
Leeds-based scientists, funded by Yorkshire Cancer Research headquartered in Harrogate, North Yorkshire, plan to introduce the genetic material of a virus into normal human skin cells to produce skin cells that have features of Merkel Cell Carcinoma cancers. Researchers at the University of...